Skip to Main Content

Author Details

Michael Slifker
Fox Chase Cancer Center
2002
53
24
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36764492TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype.Gastroenterology2023
37377901Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome-host Interactions in Oral Squamous Cell Carcinoma.Cancer Res Commun2023
36361810Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia.Int J Mol Sci2022
33210795Molecular Profiling of Exceptional Responders to Cancer Therapy.Oncologist2021
34445631Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC).Int J Mol Sci2021
33949005Analysis of differential neonatal lethality in cystathionine β-synthase deficient mouse models using metabolic profiling.FASEB J2021
34026652Corrigendum: Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.Front Oncol2021
32162254Characterizing MHC-I Genotype Predictive Power for Oncogenic Mutation Probability in Cancer Patients.Methods Mol Biol2020
32075053Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer.Int J Mol Sci2020
33457079Targeted Stat2 deletion in conventional dendritic cells impairs CTL responses but does not affect antibody production.Oncoimmunology2020
33302880Variable selection in social-environmental data: sparse regression and tree ensemble machine learning approaches.BMC Med Res Methodol2020
32116106Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma.Cancer Biol Ther2020
31151962Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.Cancer Res2019
31185277Transcriptomic changes in the prefrontal cortex of rats as a function of age and cognitive engagement.Neurobiol Learn Mem2019
31358656ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1.J Immunol2019
30923702Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC).Front Oncol2019
30922380Genomic signature of parity in the breast of premenopausal women.Breast Cancer Res2019
30705875Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.Front Oncol2019
30252908A hierarchical clustering approach to identify repeated enrollments in web survey data.PLoS One2018
27444757Lack of global epigenetic methylation defects in CBS deficient mice.J Inherit Metab Dis2017
28108626A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes.Mol Cancer Res2017
29107334MHC-I Genotype Restricts the Oncogenic Mutational Landscape.Cell2017
29176703NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.Nat Commun2017
29163805<i>Thymine DNA Glycosylase (TDG)</i> is involved in the pathogenesis of intestinal tumors with reduced <i>APC</i> expression.Oncotarget2017
29290988Estrogen metabolism in the human lung: impact of tumorigenesis, smoke, sex and race/ethnicity.Oncotarget2017
29061672miR-6883 Family miRNAs Target CDK4/6 to Induce G<sub>1</sub> Phase Cell-Cycle Arrest in Colon Cancer Cells.Cancer Res2017
28591715BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.Oncotarget2017
27391363RIPK3 Is Largely Dispensable for RIG-I-Like Receptor- and Type I Interferon-Driven Transcriptional Responses to Influenza A Virus in Murine Fibroblasts.PLoS One2016
27740936Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.Oncotarget2016
25413005Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.In Vitro Cell Dev Biol Anim2015
26238431Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.Eur Urol2015
24351440MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.Cancer Biol Ther2014
25521078Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells.PLoS Pathog2014
25387827Expression of MTAP inhibits tumor-related phenotypes in HT1080 cells via a mechanism unrelated to its enzymatic function.G3 (Bethesda)2014
24521710A global profile of gene promoter methylation in treatment-naïve urothelial cancer.Epigenetics2014
23276798Estrogen metabolism within the lung and its modulation by tobacco smoke.Carcinogenesis2013
24204800Genome-wide promoter methylome of small renal masses.PLoS One2013
23840755Germline Mutations in Mtap Cooperate with Myc to Accelerate Tumorigenesis in Mice.PLoS One2013
23592311Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.Hum Mutat2013
23271511Murine mantle cell lymphoma model cell line.Leukemia2013
22144423ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.Cancer Prev Res (Phila)2012
23057841Defining the genomic signature of the parous breast.BMC Med Genomics2012
22246627STAT1-independent control of a neurotropic measles virus challenge in primary neurons and infected mice.J Immunol2012
22025034Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.Int J Cancer2012
21576359NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.Mol Cell Biol2011
22011582Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.Proc Natl Acad Sci U S A2011
21859828Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model.Cancer Res2011
21622728Characterization of a genomic signature of pregnancy identified in the breast.Cancer Prev Res (Phila)2011
20086172The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.Cancer Res2010
20515954Early changes in gene expression induced by tobacco smoke: Evidence for the importance of estrogen within lung tissue.Cancer Prev Res (Phila)2010
  • 1 - 50 of 53

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 2
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 0
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 1
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 1
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
University of California los angeles
Career Start Year 1970
Number of shared co-authors 2

Collaborators

Co-authored papers 8
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Co-authored papers 2
Fox Chase Cancer Center
Co-authored papers 2
Universitat Pompeu Fabra
Co-authored papers 2
Fox Chase Cancer Center
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Weill Cornell School of Medicine
Co-authored papers 2
University of California Los Angeles
Co-authored papers 1
Onyx Pharmaceuticals, Inc.
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Center for Biomedical Informatics and Information Technology
Co-authored papers 1
Moores Cancer Center, University of California
Co-authored papers 1
Co-authored papers 1
Johns Hopkins School of Medicine
Co-authored papers 1
Pure MHC LLC
Co-authored papers 1
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
University of California
Co-authored papers 1
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers 1
Expert Systems Inc.
Co-authored papers 1
Universidade Federal de Santa Maria
Co-authored papers 1
the Netherlands Cancer Institute, University of California
Co-authored papers 1
University of Oklahoma Health Sciences Center
Co-authored papers 1
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1